ConductScience.org, home

Paper39835546

Exploring the Therapeutic Potential of TROP2 Gene Silencing in Hepatocellular Carcinoma.

Yakoub F and 5 others. Recent Pat Biotechnol, 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Exploring the Therapeutic Potential of TROP2 Gene Silencing in Hepatocellular Carcinoma. Papers, record 39835546. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39835546

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exploring the Therapeutic Potential of TROP2 Gene Silencing in Hepatocellular Carcinoma.
PubMed
Journal
Recent Pat Biotechnol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-02-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yakoub FFatma
2Hassan HHanemhttps://orcid.org/0000-0002-1417-1412
3Mamdouh SSamahhttps://orcid.org/0000-0001-5979-3189
4Aboushousha TTarekhttps://orcid.org/0000-0002-6686-2442
5Rashidi FBFatma B
6El-Desouky MAMohamed Ahttps://orcid.org/0000-0001-5007-5455

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Antigens, NeoplasmMajor topic
Cell Adhesion MoleculesMajor topic
Gene SilencingMajor topic
Humans
Hep G2 Cells
Cell Movement
Apoptosis
RNA, Small Interfering
Patents as Topic
Gene Expression Regulation, Neoplastic
Gene Knockdown Techniques
Tropomyosin

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BC2191Theodor Bilharz Research Institute (TBRI), Giza, EgyptPubMed

Source PubMed

Download CSV of grants

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136891606The latest global burden of liver cancer: A past and present threat.Clin Mol Hepatol2023https://conductscience.org/library/papers/36891606PubMed
236208844Global burden of primary liver cancer in 2020 and predictions to 2040.J Hepatol2022https://conductscience.org/library/papers/36208844PubMed
337744303Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma.J Hepatocell Carcinoma2023https://conductscience.org/library/papers/37744303PubMed
435699406The advanced development of molecular targeted therapy for hepatocellular carcinoma.Cancer Biol Med2022https://conductscience.org/library/papers/35699406PubMed
535600358RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?Front Oncol2022https://conductscience.org/library/papers/35600358PubMed
636971908Oral delivery of RNAi for cancer therapy.Cancer Metastasis Rev2023https://conductscience.org/library/papers/36971908PubMed
738020299Immunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancer.Oncol Lett2023https://conductscience.org/library/papers/38020299PubMed
838203255The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance.Int J Mol Sci2023https://conductscience.org/library/papers/38203255PubMed
97029529Human trophoblast cell-surface antigens defined by monoclonal antibodies.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/7029529PubMed
1036660684A literature review of the promising future of TROP2: a potential drug therapy target.Ann Transl Med2022https://conductscience.org/library/papers/36660684PubMed
1136980630Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings.Cancers (Basel)2023https://conductscience.org/library/papers/36980630PubMed
1233187148Trop2: Jack of All Trades, Master of None.Cancers (Basel)2020https://conductscience.org/library/papers/33187148PubMed
1338179054Targeting Trop2 in solid tumors: a look into structures and novel epitopes.Front Immunol2023https://conductscience.org/library/papers/38179054PubMed
1437378943Immunohistochemical Expression of CD90, CD133, and TPM1 in Relation to Gastric Cancer and H. pylori Association.Asian Pac J Cancer Prev2023https://conductscience.org/library/papers/37378943PubMed
152440339Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Anal Biochem1987https://conductscience.org/library/papers/2440339PubMed
1623841653A new method for quantitative real-time polymerase chain reaction data analysis.J Comput Biol2013https://conductscience.org/library/papers/23841653PubMed
1732723562Cyclin D-CDK4/6 functions in cancer.Adv Cancer Res2020https://conductscience.org/library/papers/32723562PubMed
1836474748MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma.Noncoding RNA Res2023https://conductscience.org/library/papers/36474748PubMed
1938339417Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape.Cancers (Basel)2024https://conductscience.org/library/papers/38339417PubMed
2037814270Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.Mol Cancer2023https://conductscience.org/library/papers/37814270PubMed

See all 31 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
TACSTD24070PubTator's text mininghttps://conductscience.org/library/genes/4070NCBI Gene
TPM17168PubTator's text mininghttps://conductscience.org/library/genes/7168NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39835546

GET https://conductscience.org/api/papers/v1/39835546/references?page=2